The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

47 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and evaluation of new endomorphin analogs with enhanced central antinociception after peripheral administration.EBI
Lanzhou University
Synthesis and biological evaluation of 2,4-diaminopyrimidines as selective Aurora A kinase inhibitors.EBI
Lanzhou University
Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent.EBI
Lanzhou University
Ingol-type diterpenes from Euphorbia antiquorum with mouse 11ß-hydroxysteroid dehydrogenase type 1 inhibition activity.EBI
Lanzhou University
Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase.EBI
Lanzhou University
Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potentµ-opioid agonists.EBI
Lanzhou University
Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking.EBI
Lanzhou University
A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.EBI
Lanzhou University
A new class of highly potent and selective endomorphin-1 analogues containinga-methylene-ß-aminopropanoic acids (map).EBI
Lanzhou University
Molecular modeling studies to predict the possible binding modes of endomorphin analogs in mu opioid receptor.EBI
Lanzhou University
Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling.EBI
Lanzhou University
Endomorphin-1 analogs with enhanced metabolic stability and systemic analgesic activity: design, synthesis, and pharmacological characterization.EBI
Lanzhou University
Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting VHL for the treatment of gastric cancer.EBI
Lanzhou University
Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities.EBI
Lanzhou University
Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors.EBI
Lanzhou University
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.EBI
Lanzhou University
Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3 or 4.EBI
Lanzhou University
-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.EBI
Lanzhou University
Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.EBI
Lanzhou University
Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2.EBI
Lanzhou University
Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors.EBI
Lanzhou University
Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.EBI
Lanzhou University
Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects.EBI
Lanzhou University
N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.EBI
Lanzhou University
Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma.EBI
Lanzhou University
Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors.EBI
Lanzhou University
Discovery of pyrazole N-aryl sulfonate: A novel and highly potent cyclooxygenase-2 (COX-2) selective inhibitors.EBI
Lanzhou University
Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.EBI
Lanzhou University
Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents.EBI
Lanzhou University
Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities.EBI
Lanzhou University
Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors.EBI
Lanzhou University
Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception.EBI
Lanzhou University
Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation.EBI
Lanzhou University
The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors.EBI
Lanzhou University
Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications.EBI
Lanzhou University
Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors.EBI
Lanzhou University
Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.EBI
Lanzhou University
Synthesis and biological evaluation of nitroxide labeled pyrimidines as Aurora kinase inhibitors.EBI
Lanzhou University
Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.EBI
Lanzhou University
Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors.EBI
Lanzhou University
CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.EBI
Lanzhou University
QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on linear and nonlinear regression methods.EBI
Lanzhou University
QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.EBI
Lanzhou University
Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors.EBI
Lanzhou University
Bioactive Glycosides from the Twigs of Litsea cubeba.EBI
Lanzhou University
Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent.EBI
Lanzhou University